Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Contour Health vs Luvo Health

Contour Health
Graded #177

Higher grade

vs+5.799999999999997
Luvo Health
Graded #305

Lower grade

The verdict

Contour Health takes it — 66.8/100 to 61/100.

Contour Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Contour Health (Desert Contour LLC) is a Utah-based telehealth provider offering compounded semaglutide and tirzepatide through a named 503A pharmacy partner, Strive Pharmacy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueContour Health +27
65
38
Dose & formulationLuvo Health +24
64
88
Clinical oversightContour Health +17
85
68
Labs & monitoringContour Health +1
53
52
FulfillmentLuvo Health +4
70
74
Contract termsContour Health +10
55
45
Contour Health · left barLuvo Health · right bar

The numbers

MetricContour HealthLuvo Health
WeighScore66.8/10061/100
GradeCC
Scorecard rank#177#305
Semaglutide$160/mo (starting dose, compounded)$249/mo (compounded)
Tirzepatide$300/mo (starting dose, compounded)$339/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Contour Health

Graded #177 · C

Strengths

  • Free medical consultation — no charge to talk with a provider before starting
  • Pay-per-vial pricing with no long-term subscription commitment required to participate
  • Names its compounding pharmacy partner (Strive Pharmacy, 503A accredited) — a real transparency signal
  • LegitScript badge links to a genuine, working LegitScript verification checker for the domain
  • Board-certified Medical Director and named nurse-practitioner care team, not anonymous providers

Where it loses points

  • State availability list is not published — Terms of Service only says "certain states"
  • All product purchases are non-refundable per Terms of Service
  • Compounded injectable only — no oral option, no brand-name Wegovy/Zepbound/Ozempic/Mounjaro
  • Terms of Service also describe an optional subscription tier with a 3-month minimum, despite marketing emphasizing "no subscriptions"
  • No insurance, Medicare, or Medicaid accepted — cash-pay or HSA/FSA only
Luvo Health

Graded #305 · C

Strengths

  • Full price list published openly, by medication and by commitment length, with no intake required
  • Offers both compounded and brand-name Ozempic and Zepbound in one place
  • Oral semaglutide tablets available as well as injections
  • Full refund if a provider disqualifies you before medication is ordered
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Billed per 4 weeks, not per month, which is 13 charges a year rather than 12
  • You are charged for the first period as soon as you complete the intake form, before a clinician has reviewed you
  • Refunds stop once medication is ordered, and for new patients with no video visit that is at intake submission
  • Cancellation needs 72 hours notice before the billing date or you are charged for another cycle
  • Bundle refunds are recalculated at the standard non-bundled rate, so the multi-month discount is clawed back

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard